I  U  P  A  C

 

 

 

News & Notices

Organizations & People

Standing Committees

Divisions

Projects

Reports

Publications
. . CI
. . PAC
. . Macro. Symp.

. . Books
. . Solubility Data

Symposia

AMP

Links of Interest

Search the Site

Home Page

 

Pure Appl. Chem. 75(11/12), 2491-2495, 2003

Pure and Applied Chemistry

Vol. 75, Issues 11-12

Application of rat medium-term bioassays for detecting carcinogenic and modifying potentials of endocrine active substances

K. Imaida, S. Tamano, A. Hagiwara, S. Fukushima, T. Shirai, and N. Ito

Faculty of Medicine, Kagawa Medical University, 1750-1 Ikenobe, Miki cho, Kitagun, Kagawa 761-0793, Japan;
Daiyu-kai Institute of Medical Sciences, 64 Gura, Nishiazai, Azai-cho, Ichinomiya 491-0113, Japan;
Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan;
Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan;
Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

Abstract: Two in vivo bioassay methods, a rat medium-term liver bioassay and a rat multiorgan bioassay, can be used for detecting carcinogenic or modifying potentials of endocrine active substances (EASs) on endocrine disruption (ED). The first bioassay, the rat mediumterm liver bioassay, is fundamentally based on the two-step hypothesis of liver carcinogenesis; initiation with diethylnitrosamine (DEN, 200 mg/kg b.w., ip) is followed by test chemical administrations during the second stage, in combination with 2/3 partial hepatectomy. It requires only eight weeks for animal experimental treatment and a further few weeks for quantitative analysis of immunohistochemically demonstrated gluthathione-S-transeferase placental form positive hepatic foci. A total of 313 chemicals/substances have already been analyzed, and the efficacy of the system for hepatocarcinogenesis has thereby been well established. This bioassay also provides information concerning dose responses and inhibitory potentials of test chemicals. Several possible EASs, most of them categorized as pesticides, have already been examined in this bioassay, and dose-response studies of nonylphenol, bisphenol A, and styrene have also been tested. Another bioassay, a medium-term, multiorgan bioassay system, using five different chemical carcinogens -DEN, MNU, BBN, DMH, and DHPN- has also been established for rapid detection of not only hepatocarcinogens, but also other organ-targeted carcinogens. These medium-term bioassays are particularly useful and reliable methods for detecting carcinogenic or modifying potentials of low doses of test chemicals, such as EASs, and these methods can be used for the effects of chemical mixtures of EASs.

*Report from a SCOPE/IUPAC project: Implication of Endocrine Active Substances for Human and Wildlife (J. Miyamoto and J.Burger, editors). Other reports are published in this issue, pp. 1617-2615.


Page last modified 12 February 2004.
Copyright © 2004 International Union of Pure and Applied Chemistry.
Questions or comments about IUPAC, please contact, the Secretariat.
Questions regarding the website, please contact web manager.